Skip to main content
NIH funding notice RFA-AI-21-006

Basic Research to Inform Vaccine and Therapeutic Development for Non-Polio Human Enteroviruses (NPEV) (R01 Clinical Trial Not Allowed)

Closed on July 13, 2021.

Posted
February 12, 2021
Close date
July 13, 2021
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

7 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $4,459,936 in first-year total cost, median $653,847.

Most frequent study sections

  1. Special Emphasis Panel[ZAI1 LR-M (J1)]7

Most frequent institutions

  1. UNIV OF NORTH CAROLINA CHAPEL HILL2
  2. STANFORD UNIVERSITY1
  3. UNIV OF MARYLAND, COLLEGE PARK1
  4. UNIVERSITY OF CALIFORNIA, SAN FRANCISCO1
  5. UNIVERSITY OF LEEDS1
Competing awards under RFA-AI-21-006 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2022Mapping spatiotemporal dynamics during enterovirus infection across cells and tissues1R01AI169460-01ANDINO, RAULSIGAL, LUIS JUNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA$868,678ZAI1
2022Enteroviral 2C protein as a therapeutic target1R01AI169462-01CAMERON, CRAIG E.UNIV OF NORTH CAROLINA CHAPEL HILL, NC$789,556ZAI1
2022Human 3D neuro-muscular assembloids to study cell tropism and host factor utilization of divergent neuropathogenic enteroviruses1R01AI169467-01CARETTE, JAN EPASCA, SERGIUSTANFORD UNIVERSITY, CA$762,346ZAI1
2022Human Antibody Cross-Reactivity in Non-Polio Enteroviruses1R01AI169461-01VOGT, MATTHEW RUNIV OF NORTH CAROLINA CHAPEL HILL, NC$653,847ZAI1
2022Understanding the fundamental enterovirus capsid assembly and maturation pathway.1R01AI169457-01STONEHOUSE, NICOLA JUNIVERSITY OF LEEDS$537,601ZAI1
2022Cell intrinsic antiviral mechanisms targeting human enteroviruses1R01AI169451-01SCHOGGINS, JOHN W.UT SOUTHWESTERN MEDICAL CENTER, TX$468,599ZAI1
2022Infection-specific lipid metabolism as a target to control enterovirus infections1R01AI169458-01BELOV, GEORGE A.UNIV OF MARYLAND, COLLEGE PARK, MD$379,309ZAI1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-AI-21-006: Basic Research to Inform Vaccine and Therapeutic Development for Non-Polio Human Enteroviruses (NPEV) (R01 Clinical Trial Not Allowed) | ScienceDex | ConductScience